NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.62 Cr | ₹0.44 Cr | ₹0.10 Cr | ₹0.28 Cr | ₹0.28 Cr |
What is the latest Contingent Liabilities ratio of NGL FINECHEM ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.62 Cr |
| Mar2024 | ₹0.44 Cr |
| Mar2023 | ₹0.10 Cr |
| Mar2022 | ₹0.28 Cr |
| Mar2021 | ₹0.28 Cr |
How is Contingent Liabilities of NGL FINECHEM Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.62 Cr | 40.59 | |
| Mar2024 | ₹0.44 Cr | 336.63 | |
| Mar2023 | ₹0.10 Cr | -63.67 | |
| Mar2022 | ₹0.28 Cr | 0.00 | |
| Mar2021 | ₹0.28 Cr | - | |
Compare Contingent Liabilities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹898.3 Cr | 1.1% | 4.9% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | -0.2% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -2.4% | 9.1% | 13.4% | Stock Analytics | |
| CIPLA | ₹127,688.0 Cr | -5.7% | 4% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.3% | 1.3% | 8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | 0.1% | 1.2% | -2.8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1.1% |
4.9% |
-22.6% |
| SENSEX | 0.7% |
4.7% |
6.1% |
You may also like the below Video Courses